Soraya Adris

604 total citations
10 papers, 520 citations indexed

About

Soraya Adris is a scholar working on Biotechnology, Oncology and Rheumatology. According to data from OpenAlex, Soraya Adris has authored 10 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biotechnology, 3 papers in Oncology and 3 papers in Rheumatology. Recurrent topics in Soraya Adris's work include Cancer Research and Treatments (4 papers), Virus-based gene therapy research (3 papers) and Bone and Dental Protein Studies (3 papers). Soraya Adris is often cited by papers focused on Cancer Research and Treatments (4 papers), Virus-based gene therapy research (3 papers) and Bone and Dental Protein Studies (3 papers). Soraya Adris collaborates with scholars based in Argentina, United Kingdom and Brazil. Soraya Adris's co-authors include Alicia Bravo, Osvaldo L. Podhajcer, José Mordoh, Laura Bover, Yuti Chernajovsky, Claudia Kairiyama, Fernanda Ledda, Cecilia Carbone, Eduardo Chuluyán and María A. Jasnis and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and Journal of Investigative Dermatology.

In The Last Decade

Soraya Adris

10 papers receiving 506 citations

Peers

Soraya Adris
Comparison fields: 5 of 66
  • Rheumatology 228
  • Oncology 202
  • Molecular Biology 151
  • Immunology 130
  • Biotechnology 97
Replace Ermira Pazolli with:
Ermira Pazolli United States
Sheng‐Ben Liang Japan
Sarah Bhargava Germany
Lindsay B. Alcaraz France
Megana Prasad United States
Tadahiro Nagaoka United States
Vincenza Lombari Italy
Orith Leitner Israel
Annie Le United States
Pouya Pakneshan Canada
Ermira Pazolli United States View profile →
Citations per field, relative to Soraya Adris
Soraya Adris · 1×
Citations per year, relative to Soraya Adris
Soraya Adris · 1×

Countries citing papers authored by Soraya Adris

Since Specialization
Citations

This map shows the geographic impact of Soraya Adris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soraya Adris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soraya Adris more than expected).

Fields of papers citing papers by Soraya Adris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soraya Adris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soraya Adris. The network helps show where Soraya Adris may publish in the future.

Co-authorship network of co-authors of Soraya Adris

This figure shows the co-authorship network connecting the top 25 collaborators of Soraya Adris. A scholar is included among the top collaborators of Soraya Adris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soraya Adris. Soraya Adris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
# Work Indexed citations
1 41
2 29
3 5
4
Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells.
27
5 7
6 60
7 200
8 145
9
Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
5
10
[The role of SPARC gene in tumorigenic capacity of human melanoma cells].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026